Apar Gupta

Employment

• Columbia University Irving Medical Center Assistant Professor
  2020 - Present
• Rutgers Cancer Institute of New Jersey Chief Resident
  2016 - 2020

Education

• Boston University School of Medicine MD
  2010 - 2015

Projects & Funding

Projects & funding information is unavailable.

Publications (15)

• Cost-Effectiveness of Adjuvant Treatment for Ductal Carcinoma In Situ
  Journal of Clinical Oncology 2021 DOI: 10.1200/JCO.21.00831
  +Save
• Use of Immunotherapy and Radiation Treatment in the Management of Metastatic Melanoma With Rhabdomyosarcomatous Differentiation
  Advances in Radiation Oncology 2020 DOI: 10.1016/j.adro.2019.07.019
  +Save
• Relationship of Cancer to Brain Aging Markers of Alzheimer's Disease: The Framingham Heart Study.
  Advances in geriatric medicine and research 2019 DOI: 10.20900/agmr20190006
  +Save
• 5-Year Results of a Prospective Phase 2 Trial Evaluating 3-Week Hypofractionated Whole Breast Radiation Therapy Inclusive of a Sequential Boost
  International Journal of Radiation Oncology*Biology*Physics 2019 DOI: 10.1016/j.ijrobp.2019.05.063
  +Save
• Insurance Approval for Proton Beam Therapy and its Impact on Delays in Treatment.
  International journal of radiation oncology, biology, physics 2018 DOI: 10.1016/j.ijrobp.2018.12.021
  +Save
• Hypofractionated radiation treatment in the management of breast cancer.
  Expert review of anticancer therapy 2018 DOI: 10.1080/14737140.2018.1489245
  +Save
• Hypofractionated whole breast irradiation is cost-effective-but is that enough to change practice?
  Translational cancer research 2018 DOI: 10.21037/tcr.2018.03.20
  +Save
• Daily Image Guidance With Cone Beam Computed Tomography May Reduce Radiation Pneumonitis in Unresectable Non-Small Cell Lung Cancer.
  International journal of radiation oncology, biology, physics 2018 DOI: 10.1016/j.ijrobp.2018.03.025
  +Save
• In Reply to Leddy.
  International journal of radiation oncology, biology, physics 2018 DOI: 10.1016/j.ijrobp.2017.11.018
  +Save
• Risk factors involved in treatment delays and differences in treatment type for patients with prostate cancer by risk category in an academic safety net hospital.
  Advances in radiation oncology 2017 DOI: 10.1016/j.adro.2017.12.002
  +Save